Parallax Volatility Advisers’s AEON Biopharma Inc AEON.WS Stock Holding History

Parallax Volatility Advisers’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,141	Closed	-$17.6K	–	2342
2024 Q1	$17.6K	Sell	12,141 -12,859	-51%	-$7.89K	﹤0.01%	1672
2023 Q4	$1.88K	Hold	25,000	–	–	﹤0.01%	2081
2023 Q3	$3.75K	Sell	25,000 -458,535	-95%	-$65K	﹤0.01%	2162
2023 Q2	$43.5K	Sell	483,535 -377,003	-44%	-$28.3K	﹤0.01%	2086
2023 Q1	$47.3K	Sell	860,538 -14,590	-2%	-$842	﹤0.01%	2225
2022 Q4	$39.9K	Sell	875,128 -283,977	-24%	-$11.5K	﹤0.01%	2394
2022 Q3	$87K	Buy	1,159,105 +122,087	+12%	+$11.1K	﹤0.01%	2504
2022 Q2	$156K	Buy	1,037,018 +273,323	+36%	+$57.5K	﹤0.01%	2264
2022 Q1	$241K	Buy	763,695 +372,006	+95%	+$153K	﹤0.01%	2127
2021 Q4	$200K	Buy	391,689 +228,940	+141%	+$127K	﹤0.01%	1651
2021 Q3	$95K	Buy	+162,749	New	+$119K	﹤0.01%	1778

Parallax Volatility Advisers's AEON.WS Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 12,141 shares — an estimated $17.6K sold.

Parallax Volatility Advisers first reported a position in AEON.WS in Q3 2021 and held it in 11 quarters. The position peaked at $241K in Q1 2022. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Parallax Volatility Advisers reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 12,141 AEON Biopharma Inc shares in Q2 2024, an estimated $17.6K.
Parallax Volatility Advisers first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 11 quarters.
Parallax Volatility Advisers's AEON Biopharma Inc position peaked at $241K in Q1 2022.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.